{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:11:58Z","timestamp":1794323518106,"version":"4.9.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"ShenKang Hospital","award":["SHDC2202230"],"award-info":[{"award-number":["SHDC2202230"]}]},{"name":"ShenKang Hospital","award":["SHDC2202230"],"award-info":[{"award-number":["SHDC2202230"]}]},{"name":"Shanghai Clinical Research Center for Kidney Disease","award":["22MC1940100"],"award-info":[{"award-number":["22MC1940100"]}]},{"name":"Shanghai Clinical Research Center for Kidney Disease","award":["22MC1940100"],"award-info":[{"award-number":["22MC1940100"]}]},{"name":"Shanghai Municipal Key Clinical Specialty","award":["shslczdzk02501"],"award-info":[{"award-number":["shslczdzk02501"]}]},{"name":"Shanghai Municipal Key Clinical Specialty","award":["shslczdzk02501"],"award-info":[{"award-number":["shslczdzk02501"]}]},{"name":"Shanghai Key laboratory of Kidney and Blood Purification","award":["20DZ227160"],"award-info":[{"award-number":["20DZ227160"]}]},{"name":"Shanghai Key laboratory of Kidney and Blood Purification","award":["20DZ227160"],"award-info":[{"award-number":["20DZ227160"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102289"],"award-info":[{"award-number":["82102289"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05276-5","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:37:59Z","timestamp":1762346279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between Neutrophil-to-Lymphocyte ratio and left ventricular hypertrophy in chronic kidney disease patients: a cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuhua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"2","key":"5276_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2215\/CJN.06980615","volume":"11","author":"E Paoletti","year":"2016","unstructured":"Paoletti E, De Nicola L, Gabbai FB, Chiodini P, Ravera M, Pieracci L, et al. Associations of left ventricular hypertrophy and geometry with adverse outcomes in patients with CKD and hypertension. Clin J Am Soc Nephrol. 2016;11(2):271\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"5276_CR2","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1681\/ASN.2004070597","volume":"16","author":"DE Weiner","year":"2005","unstructured":"Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS, et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol. 2005;16(6):1803\u201310.","journal-title":"J Am Soc Nephrol"},{"key":"5276_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.761848","volume":"9","author":"L Sun","year":"2022","unstructured":"Sun L, Li Q, Sun Z, Duan S, Nie G, Dong J, et al. Impact of overhydration on left ventricular hypertrophy in patients with chronic kidney disease. Front Nutr. 2022;9:761848.","journal-title":"Front Nutr"},{"issue":"2","key":"5276_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/j.ajkd.2005.04.031","volume":"46","author":"E Paoletti","year":"2005","unstructured":"Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G. Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis. 2005;46(2):320\u20137.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"5276_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000351758","volume":"38","author":"H Moradi","year":"2013","unstructured":"Moradi H, Sica DA, Kalantar-Zadeh K. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease. Am J Nephrol. 2013;38(2):136\u201348.","journal-title":"Am J Nephrol"},{"issue":"1","key":"5276_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5301\/JN.2010.2030","volume":"24","author":"G Cerasola","year":"2011","unstructured":"Cerasola G, Nardi E, Palermo A, Mule G, Cottone S. Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review. J Nephrol. 2011;24(1):1\u201310.","journal-title":"J Nephrol"},{"issue":"4","key":"5276_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124772","volume":"10","author":"J Gupta","year":"2015","unstructured":"Gupta J, Dominic EA, Fink JC, Ojo AO, Barrows IR, Reilly MP, et al. Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC study. PLoS ONE. 2015;10(4):e0124772.","journal-title":"PLoS ONE"},{"issue":"6","key":"5276_CR8","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/anec.12166","volume":"19","author":"JM Krepp","year":"2014","unstructured":"Krepp JM, Lin F, Min JK, Devereux RB, Okin PM. Relationship of electrocardiographic left ventricular hypertrophy to the presence of diastolic dysfunction. Ann Noninvasive Electrocardiol. 2014;19(6):552\u201360.","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"5276_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000486938","volume":"195","author":"T Ogawa","year":"2018","unstructured":"Ogawa T, Nitta K. Clinical impact of left ventricular diastolic dysfunction in chronic kidney disease. Contrib Nephrol. 2018;195:81\u201391.","journal-title":"Contrib Nephrol"},{"key":"5276_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cells12121581","author":"SP Kadatane","year":"2023","unstructured":"Kadatane SP, Satariano M, Massey M, Mongan K, Raina R. The role of inflammation in CKD. Cells. 2023. https:\/\/doi.org\/10.3390\/cells12121581.","journal-title":"Cells"},{"issue":"8","key":"5276_CR11","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00467-008-1046-0","volume":"24","author":"DM Silverstein","year":"2009","unstructured":"Silverstein DM. Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol. 2009;24(8):1445\u201352.","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"5276_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000545822","volume":"15","author":"L Wang","year":"2025","unstructured":"Wang L, Xiang F, Ji J, Zhang L, Jiang X, Fang Y, et al. Association of uric acid to high-density lipoprotein cholesterol ratio with left ventricular hypertrophy in chronic kidney disease. Cardiorenal Med. 2025;15(1):323\u201332.","journal-title":"Cardiorenal Med"},{"key":"5276_CR13","doi-asserted-by":"crossref","unstructured":"Podkowinska A, Formanowicz D. Chronic kidney disease as oxidative stress- and inflammatory-mediated cardiovascular disease. Antioxid (Basel). 2020;9(8):752.","DOI":"10.3390\/antiox9080752"},{"key":"5276_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00206","volume":"9","author":"F Li","year":"2019","unstructured":"Li F, Wang M, Wang J, Li R, Zhang Y. Alterations to the gut microbiota and their correlation with inflammatory factors in chronic kidney disease. Front Cell Infect Microbiol. 2019;9:206.","journal-title":"Front Cell Infect Microbiol"},{"key":"5276_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010531","author":"E Harlacher","year":"2022","unstructured":"Harlacher E, Wollenhaupt J, Baaten C, Noels H. Impact of uremic toxins on endothelial dysfunction in chronic kidney disease: a systematic review. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23010531.","journal-title":"Int J Mol Sci"},{"key":"5276_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-015-0068-7","volume":"16","author":"BT Lee","year":"2015","unstructured":"Lee BT, Ahmed FA, Hamm LL, Teran FJ, Chen CS, Liu Y, et al. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease. BMC Nephrol. 2015;16:77.","journal-title":"BMC Nephrol"},{"key":"5276_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2017.12.016","volume":"820","author":"W Lv","year":"2018","unstructured":"Lv W, Booz GW, Wang Y, Fan F, Roman RJ. Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets. Eur J Pharmacol. 2018;820:65\u201376.","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"5276_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138461","volume":"10","author":"K Ioannou","year":"2015","unstructured":"Ioannou K, Stel VS, Dounousi E, Jager KJ, Papagianni A, Pappas K, et al. Inflammation, endothelial dysfunction and increased left ventricular mass in chronic kidney disease (CKD) patients: a longitudinal study. PLoS ONE. 2015;10(9):e0138461.","journal-title":"PLoS ONE"},{"key":"5276_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7583690","volume":"2019","author":"M Mocan","year":"2019","unstructured":"Mocan M, Mocan Hognogi LD, Anton FP, Chiorescu RM, Goidescu CM, Stoia MA, et al. Biomarkers of inflammation in left ventricular diastolic dysfunction. Dis Markers. 2019;2019:7583690.","journal-title":"Dis Markers"},{"issue":"10","key":"5276_CR20","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cardfail.2008.07.233","volume":"14","author":"K Naito","year":"2008","unstructured":"Naito K, Anzai T, Yoshikawa T, Anzai A, Kaneko H, Kohno T, et al. Impact of chronic kidney disease on postinfarction inflammation, oxidative stress, and left ventricular remodeling. J Card Fail. 2008;14(10):831\u20138.","journal-title":"J Card Fail"},{"issue":"10","key":"5276_CR21","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.121.318159","volume":"128","author":"WJ Paulus","year":"2021","unstructured":"Paulus WJ, Zile MR. From systemic inflammation to myocardial fibrosis: the heart failure with preserved ejection fraction paradigm revisited. Circ Res. 2021;128(10):1451\u201367.","journal-title":"Circ Res"},{"issue":"23","key":"5276_CR22","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","volume":"54","author":"P Libby","year":"2009","unstructured":"Libby P, Ridker PM, Hansson GK. Leducq transatlantic network on A: inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129\u201338.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"5276_CR23","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s10157-012-0728-x","volume":"17","author":"Y Solak","year":"2013","unstructured":"Solak Y, Yilmaz MI, Sonmez A, Saglam M, Cakir E, Unal HU, et al. Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease. Clin Exp Nephrol. 2013;17(4):532\u201340.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"5276_CR24","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/0886022X.2020.1832521","volume":"42","author":"WM Zhao","year":"2020","unstructured":"Zhao WM, Tao SM, Liu GL. Neutrophil-to-lymphocyte ratio in relation to the risk of all-cause mortality and cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis. Ren Fail. 2020;42(1):1059\u201366.","journal-title":"Ren Fail"},{"issue":"11","key":"5276_CR25","first-page":"5063","volume":"9","author":"L Fang","year":"2017","unstructured":"Fang L, Ellims AH, Beale AL, Taylor AJ, Murphy A, Dart AM. Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy. Am J Transl Res. 2017;9(11):5063\u201373.","journal-title":"Am J Transl Res"},{"issue":"3","key":"5276_CR26","doi-asserted-by":"publisher","first-page":"H375","DOI":"10.1152\/ajpheart.00633.2016","volume":"312","author":"H Toba","year":"2017","unstructured":"Toba H, Cannon PL, Yabluchanskiy A, Iyer RP, D\u2019Armiento J, Lindsey ML. Transgenic overexpression of macrophage matrix metalloproteinase-9 exacerbates age-related cardiac hypertrophy, vessel rarefaction, inflammation, and fibrosis. Am J Physiol Heart Circ Physiol. 2017;312(3):H375-83.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"5276_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1536\/ihj.19-138","volume":"61","author":"X Yu","year":"2020","unstructured":"Yu X, Xue Y, Bian B, Wu X, Wang Z, Huang J, et al. NLR-a simple indicator of inflammation for the diagnosis of left ventricular hypertrophy in patients with hypertension. Int Heart J. 2020;61(2):373\u20139.","journal-title":"Int Heart J"},{"key":"5276_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.921204","volume":"9","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Li G, Laukkanen JA, Song X, Zhang J, Wei L, et al. Higher neutrophil to lymphocyte ratio is associated with renal dysfunction and cardiac adverse remodeling in elderly with metabolic syndrome. Front Cardiovasc Med. 2022;9:921204.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"5276_CR29","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67(6):2089\u2013100.","journal-title":"Kidney Int"},{"issue":"19","key":"5276_CR30","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"issue":"3","key":"5276_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/1358863x06070516","volume":"11","author":"M Gerhard-Herman","year":"2006","unstructured":"Gerhard-Herman M, Gardin JM, Jaff M, Mohler E, Roman M, Naqvi TZ. American society of E, society for vascular M, biology: guidelines for noninvasive vascular laboratory testing: a report from the American society of echocardiography and the society for vascular medicine and biology. Vasc Med. 2006;11(3):183\u2013200.","journal-title":"Vasc Med"},{"issue":"2","key":"5276_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.euje.2005.12.014","volume":"7","author":"RM Lang","year":"2006","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79\u2013108.","journal-title":"Eur J Echocardiogr"},{"issue":"2","key":"5276_CR33","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/ndt\/gfr282","volume":"27","author":"J Payne","year":"2012","unstructured":"Payne J, Sharma S, De Leon D, Lu JL, Alemu F, Balogun RA, et al. Association of echocardiographic abnormalities with mortality in men with non-dialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2012;27(2):694\u2013700.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"5276_CR34","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1093\/ndt\/gfab350","volume":"37","author":"G Lano","year":"2022","unstructured":"Lano G, Sallee M, Pelletier M, Bataille S, Fraisse M, McKay N, et al. Neutrophil:lymphocyte ratio correlates with the uremic toxin indoxyl sulfate and predicts the risk of death in patients on hemodialysis. Nephrol Dial Transplant. 2022;37(12):2528\u201337.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"5276_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10157-020-01975-9","volume":"25","author":"G Ao","year":"2021","unstructured":"Ao G, Wang Y, Qi X, Wang F, Wen H. Association of neutrophil-to-lymphocyte ratio and risk of cardiovascular or all-cause mortality in chronic kidney disease: a meta-analysis. Clin Exp Nephrol. 2021;25(2):157\u201365.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"5276_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10157-018-1605-z","volume":"23","author":"K Nitta","year":"2019","unstructured":"Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, et al. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study. Clin Exp Nephrol. 2019;23(1):85\u201398.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"5276_CR37","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.atherosclerosis.2011.02.017","volume":"216","author":"A Recio-Mayoral","year":"2011","unstructured":"Recio-Mayoral A, Banerjee D, Streather C, Kaski JC. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease\u2013a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis. 2011;216(2):446\u201351.","journal-title":"Atherosclerosis"},{"issue":"4","key":"5276_CR38","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/HYPERTENSIONAHA.111.174557","volume":"58","author":"BC van Bussel","year":"2011","unstructured":"van Bussel BC, Schouten F, Henry RM, Schalkwijk CG, de Boer MR, Ferreira I, et al. Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period. Hypertension. 2011;58(4):588\u201395.","journal-title":"Hypertension"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05276-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05276-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05276-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:38:02Z","timestamp":1762346282000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05276-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5276"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05276-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"31 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The datasets used and\/or analysed during the current study available from the corresponding author on reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"786"}}